Casdin Capital as of June 30, 2019
Portfolio Holdings for Casdin Capital
Casdin Capital holds 31 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spark Therapeutics | 8.5 | $91M | 885k | 102.38 | |
| Invitae (NVTAQ) | 8.4 | $90M | 3.8M | 23.50 | |
| Blueprint Medicines (BPMC) | 8.3 | $89M | 940k | 94.33 | |
| Codexis (CDXS) | 8.1 | $87M | 5.1M | 17.05 | |
| Sage Therapeutics (SAGE) | 6.8 | $73M | 400k | 183.09 | |
| Myokardia | 6.0 | $64M | 1.3M | 50.14 | |
| Fate Therapeutics (FATE) | 4.8 | $52M | 2.6M | 20.30 | |
| Sarepta Therapeutics (SRPT) | 4.8 | $51M | 335k | 151.95 | |
| Bluebird Bio (BLUE) | 4.4 | $47M | 373k | 127.20 | |
| Alnylam Pharmaceuticals (ALNY) | 4.4 | $47M | 650k | 72.56 | |
| Magenta Therapeutics | 4.2 | $44M | 3.0M | 14.75 | |
| Biolife Solutions (BLFS) | 3.7 | $39M | 2.4M | 16.23 | |
| Audentes Therapeutics | 3.4 | $37M | 965k | 37.86 | |
| Voyager Therapeutics (VYGR) | 2.9 | $31M | 1.1M | 27.22 | |
| Agios Pharmaceuticals (AGIO) | 2.3 | $25M | 495k | 49.88 | |
| Illumina (ILMN) | 2.1 | $22M | 60k | 368.15 | |
| GenMark Diagnostics | 2.0 | $22M | 3.4M | 6.49 | |
| Adaptive Biotechnologies Cor (ADPT) | 1.9 | $20M | 463k | 43.40 | |
| Gritstone Oncology Ord (GRTSQ) | 1.9 | $20M | 1.8M | 11.14 | |
| Constellation Pharmceticls I | 1.8 | $19M | 1.5M | 12.28 | |
| Sangamo Biosciences (SGMO) | 1.5 | $17M | 1.5M | 10.77 | |
| Global Blood Therapeutics In | 1.5 | $16M | 300k | 52.60 | |
| Homology Medicines | 1.4 | $15M | 745k | 19.57 | |
| Editas Medicine (EDIT) | 1.1 | $12M | 480k | 24.74 | |
| Alector (ALEC) | 0.9 | $10M | 551k | 18.49 | |
| Twist Bioscience Corp (TWST) | 0.8 | $8.7M | 300k | 29.01 | |
| Denali Therapeutics (DNLI) | 0.8 | $8.3M | 400k | 20.76 | |
| Caredx (CDNA) | 0.7 | $7.2M | 200k | 35.99 | |
| Turning Point Therapeutics I | 0.2 | $2.4M | 60k | 40.70 | |
| Stoke Therapeutics (STOK) | 0.2 | $2.5M | 85k | 29.17 | |
| Orchard Therapeutics Plc ads | 0.1 | $1.4M | 100k | 13.99 |
